Market Tracker

07/25 11:59am ET

Merrimack Pharmaceuticals Inc (NASDAQ:MACK)

5.39
BATS BZX Real-Time Price
As of 11:59am ET
 -0.1099 / -2.00%
Today’s Change
5.02
Today|||52-Week Range
11.18
-31.77%
Year-to-Date
Celgene's Revlimid Gains EU Nod for Mantle Cell Lymphoma
Jul 18 / Zacks.com - Paid Partner Content
Merrimack Pharmaceuticals Stock Sank Like a Stone in June
Jul 13 / MotleyFool.com - Paid Partner Content
ZIOPHARM (ZIOP) Stock Down on Patient Death in Phase I
Jul 18 / Zacks.com - Paid Partner Content
BioDelivery Sciences (BDSI) Catches Eye: Stock Rises 12%
Jul 13 / Zacks.com - Paid Partner Content
Gilead's HCV Drug Epclusa Gets Regulatory Nod in Canada
Jul 15 / Zacks.com - Paid Partner Content
CytRx (CYTR) Stock Falls on Unfavorable Aldoxorubicin Data
Jul 13 / Zacks.com - Paid Partner Content
Ultragenyx (RARE) Reports Positive Phase III rhGUS Data
Jul 15 / Zacks.com - Paid Partner Content
Comeback for Juno (JUNO) Stock? FDA Lifts Clinical Hold
Jul 13 / Zacks.com - Paid Partner Content
Bayer Expands Drug Discovery Collaboration with X-Chem
Jul 13 / Zacks.com - Paid Partner Content
 

Today’s Trading

Previous close5.50
Today’s open5.62
Day’s range5.39 - 5.62
Volume47,897
Average volume (3 months)1,785,100
Market cap$702.5M
Dividend yield--
Data as of 11:59am ET, 07/25/2016

Growth & Valuation

Earnings growth (last year)-66.25%
Earnings growth (this year)+35.59%
Earnings growth (next 5 years)+5.61%
Revenue growth (last year)-13.14%
P/E ratioNM
Price/Sales9.86
Price/Book--

Competitors

 Today’s
change
Today’s
% change
SGNTSagent Pharmaceutica...-0.02-0.07%
EGRXEagle Pharmaceutical...+0.33+0.72%
SGYPSynergy Pharmaceutic...-0.08-2.00%
INSMInsmed Inc-0.05-0.45%
Data as of 11:59am ET, 07/25/2016

Financials

Next reporting dateAugust 8, 2016
EPS forecast (this quarter)-$0.27
Annual revenue (last year)$89.3M
Annual profit (last year)-$148.0M
Net profit margin-165.76%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Robert J. Mulroy
Head-
Corporate Operations
William M. McClements
Corporate headquarters
Cambridge, Massachusetts

Forecasts